UGT1A1 gene
The UGT1A1 gene provides instructions for making an enzyme essential for processing bilirubin, a substance produced when red blood cells break down.
Normal Function
The UGT1A1 gene belongs to a family of genes that provide instructions for making enzymes called UDP-glucuronosyltransferases. These enzymes perform a chemical reaction called glucuronidation, in which a compound called glucuronic acid is attached to various substances.
The protein produced from the UGT1A1 gene, called the bilirubin uridine diphosphate glucuronosyl transferase (bilirubin-UGT) enzyme, is the only enzyme that glucuronidates bilirubin. This enzyme converts the toxic form of bilirubin (unconjugated bilirubin) to its nontoxic form (conjugated bilirubin), allowing it to be dissolved and removed from the body. The bilirubin-UGT enzyme is primarily found in liver cells, where conjugated bilirubin is dissolved in bile and excreted with solid waste.
Health Conditions Related to Genetic Changes
Crigler-Najjar syndrome
At least 85 mutations in the UGT1A1 gene are associated with Crigler-Najjar syndrome, which occurs when both copies of the gene are altered. This condition is characterized by high levels of unconjugated bilirubin in the blood (unconjugated hyperbilirubinemia) and yellowing of the skin and eyes (jaundice).
- Crigler-Najjar syndrome type 1 (CN1): Individuals have no enzyme function, leading to severe symptoms.
- Crigler-Najjar syndrome type 2 (CN2): Individuals have less than 20 percent of normal enzyme function.
- Kernicterus: A form of brain damage caused by the accumulation of unconjugated bilirubin in the brain, which can be lethal.
Gilbert syndrome
Gilbert syndrome is characterized by periods of mild unconjugated hyperbilirubinemia. It occurs when both copies of the UGT1A1 gene are altered, resulting in approximately 30 percent of normal enzyme function.
- UGT1A1*28: The most common genetic change in many populations, involving an extra TA nucleotide pair in the promoter region, which impairs protein production.
- Gly71Arg (G71R): A common missense mutation in Asian populations that results in reduced enzyme function.
Other disorders
- Transient familial neonatal hyperbilirubinemia: Mutations in the UGT1A1 gene increase the risk of severe jaundice in newborns, which usually resolves in 1 to 2 weeks.
- Breast milk jaundice: A condition where unconjugated bilirubin levels increase during breastfeeding. It is thought that a substance in breast milk may trigger bilirubin buildup in infants who already have impaired bilirubin-UGT enzyme function due to a UGT1A1 gene mutation.
